Abstract:In multiple sclerosis, while remarkable progress has been accomplished to control the inflammatory component of the disease, repair of demyelinated lesions is still an unmet need. Despite encouraging results generated in experimental models, several candidates favouring or promoting remyelination have not reached the expected outcomes in clinical trials. One possible reason for these failures is that, in most cases, during preclinical testing, efficacy was evaluated on histology only, while functional recovery had not been assessed. We have generated a Xenopus laevis transgenic model Tg(mbp:GFP-NTR) of conditional demyelination in which spontaneous remyelination can be accelerated using candidate molecules. Xenopus laevis is a classic model for in vivo studies of myelination because tadpoles are translucent. We reasoned that demyelination should translate into loss of sensorimotor functions followed by behavioural recovery upon remyelination. To this end, we measured the swimming speed and distance travelled before and after demyelination and during the ongoing spontaneous remyelination and have developed a functional assay based on the visual avoidance of a virtual collision. Here we show that alteration of these functional and clinical performances correlated well with the level of demyelination and that histological remyelination, assayed by counting in vivo the number of myelinating oligodendrocytes in the optic nerve, translated in clinical-functional recovery. This method was further validated in tadpoles treated with pro-remyelinating agents (clemastine, siponimod) showing that increased remyelination in the optic nerve was associated with functional improvement. Our data illustrate the potential interest of correlating histopathological parameters and functional-clinical parameters to screen molecules promoting remyelination in a simple in vivo model of conditional demyelination.

Development of Zebrafish Demyelination Model for Evaluation of Remyelination Compounds and RORγt Inhibitors.

A novel model of demyelination and remyelination in a GFP-transgenic zebrafish.

Zebrafish: a novel animal model for demyelination and remyelination

Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model

Inhibition of RIPK1 by ZJU-37 Promotes Oligodendrocyte Progenitor Proliferation and Remyelination Via NF-κB Pathway

Monitoring recovery after CNS demyelination, a novel tool to de-risk pro-remyelinating strategies

[Mechanisms Underlying Remyelination with Special Focus on Demyelination Models of Multiple Sclerosis].

Zebrafish as a Model for Multiple Sclerosis

Lymphotoxin Β Receptor (ltβr): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using LtβR–Ig Protein

Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein.

17β-Estradiol Enhances Schwann Cell Differentiation via the ERβ-ERK1/2 Signaling Pathway and Promotes Remyelination in Injured Sciatic Nerves

Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye

Emerging concepts in oligodendrocyte and myelin formation, inputs from the zebrafish model

Celecoxib Exerts a Therapeutic Effect Against Demyelination by Improving the Immune and Inflammatory Microenvironments

Lymphotoxin Receptor (Lt R): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using Lt R-Ig Protein

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

Accelerated Remyelination During Inflammatory Demyelination Prevents Axonal Loss and Improves Functional Recovery

Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model

Down-regulation of Interleukin 7 Receptor (IL-7R) Contributes to Central Nervous System Demyelination

Remyelination protects neurons from DLK-mediated neurodegeneration

Remyelination reporter reveals prolonged refinement of spontaneously regenerated myelin